Pages that link to "Q37637949"
Jump to navigation
Jump to search
The following pages link to Current and Potential Uses of Immunocytokines as Cancer Immunotherapy (Q37637949):
Displaying 17 items.
- Immunocytokines and bispecific antibodies: two complementary strategies for the selective activation of immune cells at the tumor site (Q28066935) (← links)
- A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors (Q34548847) (← links)
- Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution (Q35212575) (← links)
- Production of an active anti-CD20-hIL-2 immunocytokine in Nicotiana benthamiana. (Q35603066) (← links)
- Different tissue distribution properties for glycosylation variants of fusion proteins containing the p40 subunit of murine interleukin-12. (Q37559740) (← links)
- Immunocytokines for cancer treatment: past, present and future (Q37560208) (← links)
- Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs (Q38364462) (← links)
- Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation (Q38974641) (← links)
- Delivering safer immunotherapies for cancer (Q39330984) (← links)
- Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016. (Q46721978) (← links)
- Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins (Q47277628) (← links)
- N-glycan engineering of a plant-produced anti-CD20-hIL-2 immunocytokine significantly enhances its effector functions (Q47311471) (← links)
- Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo (Q50544077) (← links)
- Addressing the Immunogenicity of the Cargo and of the Targeting Antibodies with a Focus on Demmunized Bacterial Toxins and on Antibody-Targeted Human Effector Proteins (Q50962872) (← links)
- Antibody-Based Targeted Delivery of Interleukin-22 Promotes Rapid Clinical Recovery in Mice With DSS-Induced Colitis (Q51599949) (← links)
- Outcome-related signatures identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated After Starting Hu14.18-IL2 (Q90169746) (← links)
- Interferons α and β in cancer: therapeutic opportunities from new insights (Q91212056) (← links)